Julie Yu Net Worth & Insider Trades

Julie Yu - VP Clinical Ops & Data Mgmt, Amicus Therapeutics Inc

As of June 16, 2015

What is Julie Yu's Net Worth?

The current estimated net worth of Amicus Therapeutics Inc's VP Clinical Ops & Data Mgmt, Julie Yu, is estimated to be about $745.21K . Julie Yu owns about 0 unit of Amicus Therapeutics Inc common stock. In the last year at Amicus Therapeutics Inc, Julie Yu has sold an estimated value of $438.46K worth.

What is Julie Yu's Past Insider Trading?

Julie Yu's largest purchase order was 7,785 units , worth over $89.59K on March 25, 2015. Julie Yu's largest sale order was 16,805 units , worth over $181.83K on May 12, 2015. In total, Julie Yu has made about 10 transactions over a year of their time at Amicus Therapeutics Inc. Julie Yu usually trades in June, with the busiest year in 2014 and 2015. The most recent transaction was a sale order of 8,195 units , worth over $116.12K on June 16, 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Julie Yu's' Mailing Address?

  • Mailing address is C/o Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 NJ

Amicus Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
John F. Crowley 2020 $719,514 $514,800 $5,479,971 $2,492,491 $1,282,843 $825,505 $11,315,124
John F. Crowley 2019 $656,770 $476,815 $5,327,948 $2,334,850 $234,775 $821,505 $9,852,663
John F. Crowley 2018 $637,640 $445,710 $3,861,699 $1,654,347 - $820,567 $7,419,963
Daphne Quimi 2020 $45 $228,712 $1,534,382 $697,894 - $34,639 $2,947,
Daphne Quimi 2019 $400,000 $212,960 $1,311,492 $538,808 - $17,487 $2,480,747
Daphne Quimi 2018 - - - - - - -
Bradley L. Campbell 2020 $515, $368,872 $2,557,304 $1,163,159 - $33,694 $4,
Bradley L. Campbell 2019 $500,877 $378,788 $2,254,114 $987,822 - $19,538 $4,141,139
Bradley L. Campbell 2018 $468,109 $327,209 $1,411,802 $604,817 - $16,710 $2,828,646
Hung Do 2020 $42 $187,908 $1,461,322 $664,660 - $31,248 $2,772,106
Hung Do 2019 $414,625 $200,678 $1,393,462 $574,732 - $22,129 $2,605,626
Hung Do 2018 - - - - - - -
Ellen S. Rosenberg 2020 $452, $199,051 $1,461,322 $664,660 $87,751 $20,748 $2,885,820
Ellen S. Rosenberg 2019 $439,213 $233,837 $1,393,462 $610,648 - $13,538 $2,690,698
Ellen S. Rosenberg 2018 $426,420 $208,647 $996,591 $426,933 - $18,270 $2,076,862
Jay Barth 2020 $366,269 - $1,315,184 $598,197 - $641,306 $2,920,956
Jay Barth 2019 $471,621 $228,265 $1,229,522 $538,808 - $15,998 $2,484,214
Jay Barth 2018 $457,885 $192,037 $996,591 $426,933 - $18,790 $2,092,236
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm

What are Amicus Therapeutics Inc's Past Insider Trades?

Amicus Therapeutics Inc's most recent insider trade came on August 9, 2022 by Daphne Quimi who sold 5,798 units worth $69.58K . In the last 15 years, insiders at Amicus Therapeutics Inc have sold an estimated value of $174.83M and bought an estimated value of $192.08M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman,  Bradley Campbell, President & CEO,  and James N Topper, Director .

AMICUS THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1